PersImmune is a clinical-stage immunotherapy company whose mission is to provide cancer patients with optimized immunotherapy that is personalized on the basis of their own unique tumor signature. Just as no two people are alike, no two cancers are exactly alike; because of this, the same immunotherapy treatment that works for one patient may not work well in another. To address this treatment disparity, PersImmune's proprietary protocol, Personal Adoptive Cellular Therapy for Neoantigens (PACTN) identifies the DNA alterations present in the cancer cells of each patient and generates enriched, tested, highly-specific T-cells that effectively kill the patient’s tumor cells. These are the patient's own cells, and are not edited or genetically engineered which means patients will experience far less side effects than from chemotherapy or other methods of immunotherapy.
Personalized adoptive cellular therapy has the potential to transform the field of cancer treatment by providing safe, highly-tolerable, effective immunotherapy to cancer patients. Personal immunotherapy - because no two patients are exactly alike.
PersImmune is currently accepting patients for the Phase 1 clinical trial of its Personalized Adoptive Cell Transfer technology targeting Neoantigens (PACTN). The trial provides a therapy for early and late stage patients of myelodysplastic syndrome (MDS).
Company Details
- Employees
- 2
- Founded
- -
- Address
- 11555 Sorrento Valley Rd, San Diego,california 92121,united States
- Phone
- (858) 704-4499
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- persimmune.com
- Keywords
- cancer research, immunotherapy, adoptive cell transfer, clinical trial, biotechnology, MDS, myelodysplastic syndrome, blood cancers, tumor, dna sequencing, genetics.
- HQ
- San Diego, California
Persimmune Questions
Persimmune's helpline number is (858) 704-4499
Persimmune's website is persimmune.com
Persimmune's LinkedIn profile is https://www.linkedin.com/company/persimmune
Persimmune has
2 employees.
View email and phone details for 2
employees at Persimmune.
Persimmune's industry is
Biotechnology Research
Persimmune's top competitors are
Chromis Therapeutics,
Nielsen Biosciences, Inc.,
Zelluna,
Metacrine, Inc.,
Genegocell Inc.,
Primmune Therapeutics,
Immunoscape,
Lynx Biosciences, Inc.,
Prominex Inc.,
Xcelthera Inc.
Persimmune's categories are Biotechnology Research
Persimmune's founding year is 2009
